Advertisement

Related Videos

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Advertisement

Advertisement




Jan
26
Today In Oncology
New Report Shows Colorectal Cancer is Now Leading Cancer Death Among Those Under 50
Pembrolizumab Plus Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma
Cabozantinib and Temozolomide in Unresectable or Metastatic Leiomyosarcoma
Nutrition Muscle Loss Compromises Survival in Patients With Cervical Cancer Undergoing Chemoradiotherapy
Leader in Global Cancer Care, Paul E. Goss, MD, PhD, Dies at 70
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo